StockerBroker

Maybe a runner

NASDAQ:ENTX   Entera Bio Ltd.
This has news AH that clinical trials have good results. 70% success rate. Went above its previous support of $3.80 from March of 2019 and stayed above that all day. If it bounces of that support in the morning dip, would be an excellent point to buy.

Second resistance level is around $5. If it breaks that before open then that's a clear breakout.
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.